205 related articles for article (PubMed ID: 19402057)
1. Tissue biomarkers in renal cell carcinoma: issues and solutions.
Di Napoli A; Signoretti S
Cancer; 2009 May; 115(10 Suppl):2290-7. PubMed ID: 19402057
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and prognostic markers of renal cell carcinoma].
Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
[TBL] [Abstract][Full Text] [Related]
4. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX immunohistochemistry has potential to predict renal cell carcinoma outcomes: A systematic review and meta-analyses.
Samberkar S; Rajandram R; Mun KS; Samberkar P; Danaee M; Zulkafli IS
Malays J Pathol; 2019 Dec; 41(3):233-242. PubMed ID: 31901907
[TBL] [Abstract][Full Text] [Related]
8. [Metabonome in Early Diagnosis of Renal Cell Carcinoma].
Wang Z; Zhang YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):709-713. PubMed ID: 31699205
[TBL] [Abstract][Full Text] [Related]
9. Renal tumors: diagnostic and prognostic biomarkers.
Tan PH; Cheng L; Rioux-Leclercq N; Merino MJ; Netto G; Reuter VE; Shen SS; Grignon DJ; Montironi R; Egevad L; Srigley JR; Delahunt B; Moch H;
Am J Surg Pathol; 2013 Oct; 37(10):1518-31. PubMed ID: 24025522
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA
Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
12. Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer.
Oto J; Plana E; Sánchez-González JV; García-Olaverri J; Fernández-Pardo Á; España F; Martínez-Sarmiento M; Vera-Donoso CD; Navarro S; Medina P
Curr Urol Rep; 2020 Mar; 21(2):11. PubMed ID: 32166474
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma.
He ZH; Qin XH; Zhang XL; Yi JW; Han JY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):46-54. PubMed ID: 29364470
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
15. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Biomarkers in the Management of Renal Cell Carcinoma.
Reese S; Calderon L; Khaleel S; Hakimi AA
Urol Clin North Am; 2023 Feb; 50(1):151-159. PubMed ID: 36424079
[TBL] [Abstract][Full Text] [Related]
17. PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
Ozcan A; Zhai J; Hamilton C; Shen SS; Ro JY; Krishnan B; Truong LD
Am J Clin Pathol; 2009 Mar; 131(3):393-404. PubMed ID: 19228645
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
[TBL] [Abstract][Full Text] [Related]
19. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]